Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Lilly's Pivotal Phase 3 Atopic Dermatitis Studies
Posted:
Millions of people with atopic dermatitis cope with both seen and unseen burdens of the disease. Discover more about important new clinical trial results and how Lilly is helping to improve care and understanding of this disease here.
Generative AI voice agents—conversational systems powered by large language models that can understand and produce natural speech in real time—are poised to transform how health systems engage with patients.
Read more here.
Stanford Medicine researchers developed a way to create the first heart and liver organoids that generate their own blood vessels, possibly paving the way for organoid-based regenerative therapies.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us